연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1191. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.
Lee KM, Choi EJ, Kim IA.
Radiother Oncol. 2011 Oct;101(1):171-6. Epub 2011 Jun 14.
Link
1190. Identification and functional characterization of ion channels in CD34(+) hematopoietic stem cells from human peripheral blood.
Park KS, Pang B, Park SJ, Lee YG, Bae JY, Park S, Kim I, Kim SJ.
Mol Cells. 2011 Aug;32(2):181-8. Epub 2011 Jun 1.
Link
1189. Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.
Koh Y, Kim I, Shin DY, Bae JY, Kim HK, Yoon SS, Park SS, Lee DS, Park S, Kim BK.
Biol Blood Marrow Transplant. 2012 Jan;18(1):37-43. Epub 2011 Sep 5.
Link
1188. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO, Kim YT, Jung KC, Jeon YK, Kim BH, Kim CW.
Lung Cancer. 2011 Feb;71(2):209-16. Epub 2010 May 14.
Link
1187. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.
Lee YS, Kim SH, Cho JA, Kim CW.
Exp Mol Med. 2011 May 31;43(5):281-90. doi: 10.3858/emm.2011.43.5.029.
Link
1186. Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination.
Choi Y, Jeon YH, Jang JY, Chung JK, Kim CW.
Mol Ther. 2011 May;19(5):979-89. Epub 2010 Nov 9.
Link
1185. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
Paik JH, Jang JY, Jeon YK, Kim WY, Kim TM, Heo DS, Kim CW.
Clin Cancer Res. 2011 Jul 15;17(14):4761-71. Epub 2011 May 24.
Link
1184. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.
Mol Cancer. 2011 Aug 16;10:98.
Link
1183. Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
Kim JS, Kim MA, Oh DY, Lee SH, Kim DW, Im SA, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Kim TY, Kim TM, Kim NK, Choe KJ.
Jpn J Clin Oncol. 2011 Feb;41(2):245-52. Epub 2010 Nov 24.
Link
1182. Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab.
Chang HJ, Han SW, Oh DY, Im SA, Jeon YK, Park IA, Han W, Noh DY, Bang YJ, Kim TY.
Jpn J Clin Oncol. 2011 May;41(5):593-9. Epub 2011 Mar 15.
Link